title: Role of protein flexibility in the design of Bcl-X(L) targeting agents: insight from molecular dynamics.
abstract: Detailed understanding of protein-ligand interactions is crucial to the design of more effective drugs. This is particularly true when targets are protein interfaces which have flexible, shallow binding sites that exhibit substantial structural rearrangement upon ligand binding. In this study, we use molecular dynamics simulations and free energy calculations to explore the role of ligand-induced conformational changes in modulating the activity of three generations of Bcl-X(L) inhibitors. We show that the improvement in the binding affinity of each successive ligand design is directly related to a unique and measurable reduction in local flexibility of specific regions of the binding groove, accompanied by the corresponding changes in the secondary structure of the protein. Dynamic analysis of ligand-protein interactions reveals that the latter evolve with each new design consistent with the observed increase in protein stability, and correlate well with the measured binding affinities. Moreover, our free energy calculations predict binding affinities which are in qualitative agreement with experiment, and indicate that hydrogen bonding to Asn100 could play a prominent role in stabilizing the bound conformations of latter generation ligands, which has not been recognized previously. Overall our results suggest that molecular dynamics simulations provide important information on the dynamics of ligand-protein interactions that can be useful in guiding the design of small-molecule inhibitors of protein interfaces.
authors.affiliation: Department of Chemistry, Boston College, 2609 Beacon Street, Chestnut Hill, MA 02135, USA.
authors.forename: William
authors.initials: W
authors.lastname: Novak
authors.forename: Hongming
authors.initials: H
authors.lastname: Wang
authors.forename: Goran
authors.initials: G
authors.lastname: Krilov
mesh_terms: D015195:Drug Design; D008024:Ligands; D008958:Models, Molecular; D011487:Protein Conformation; D051020:bcl-X Protein / Q000737:chemistry* / Q000187:drug effects*
chemical_list: D008024:Ligands; D051020:bcl-X Protein
references.citation: Nature. 2005 Jun 2;435(7042):677-81
references.pmid: 15902208
references.citation: J Med Chem. 2006 Feb 9;49(3):1165-81
references.pmid: 16451081
references.citation: Nat Rev Drug Discov. 2004 Apr;3(4):301-17
references.pmid: 15060526
references.citation: Science. 1997 Feb 14;275(5302):983-6
references.pmid: 9020082
references.citation: Protein Sci. 2000 Dec;9(12):2528-34
references.pmid: 11206074
references.citation: J Med Chem. 2007 Feb 22;50(4):641-62
references.pmid: 17256834
references.citation: Angew Chem Int Ed Engl. 2005 Jul 4;44(27):4130-63
references.pmid: 15954154
references.citation: Biochim Biophys Acta. 2004 Mar 1;1644(2-3):229-49
references.pmid: 14996506
references.citation: Science. 1996 Nov 29;274(5292):1531-4
references.pmid: 8929414
references.citation: Bioorg Med Chem. 2007 Oct 1;15(19):6407-17
references.pmid: 17629704
references.citation: Semin Cancer Biol. 2003 Apr;13(2):115-23
references.pmid: 12654255
references.citation: Curr Med Chem Anticancer Agents. 2002 Mar;2(2):311-30
references.pmid: 12678748
references.citation: Cancer Cell. 2002 Feb;1(1):19-30
references.pmid: 12086884
references.citation: Mol Immunol. 2003 Jan;39(11):615-47
references.pmid: 12493639
references.citation: J Med Chem. 2006 Jan 26;49(2):656-63
references.pmid: 16420051
references.citation: J Am Chem Soc. 2006 Dec 20;128(50):16206-12
references.pmid: 17165773
references.citation: Cancer Res. 2000 Nov 1;60(21):6101-10
references.pmid: 11085534
references.citation: J Med Chem. 2007 Jul 26;50(15):3457-64
references.pmid: 17602601
references.citation: J Comput Chem. 2005 Dec;26(16):1701-18
references.pmid: 16211538
references.citation: J Biol Chem. 1998 Jun 19;273(25):15458-63
references.pmid: 9624131
references.citation: J Am Chem Soc. 2002 Feb 20;124(7):1234-40
references.pmid: 11841292
references.citation: J Cell Biochem. 2006 Sep 1;99(1):305-18
references.pmid: 16619258
references.citation: J Comput Aided Mol Des. 2004 Jan;18(1):13-22
references.pmid: 15143800
references.citation: J Mol Biol. 2007 Aug 24;371(4):1099-117
references.pmid: 17597151
references.citation: Phys Rev A Gen Phys. 1985 Mar;31(3):1695-1697
references.pmid: 9895674
references.citation: Cell Res. 2006 Feb;16(2):203-13
references.pmid: 16474435
references.citation: Biochim Biophys Acta. 2004 Mar 1;1644(2-3):83-94
references.pmid: 14996493
references.citation: J Biol Chem. 2004 Jan 16;279(3):2159-65
references.pmid: 14534311
references.citation: Nat Rev Cancer. 2002 Sep;2(9):647-56
references.pmid: 12209154
references.citation: Angew Chem Int Ed Engl. 2003 Jun 6;42(22):2462-81
references.pmid: 12800163
references.citation: Nature. 1996 May 23;381(6580):335-41
references.pmid: 8692274